Department of Urology
-
October 29, 2014
Key to prostate cancer resistance
A combination of two types of therapy may be more effective in treating castration-resistant prostate cancer. -
September 11, 2014
Penson to lead Department of Urologic Surgery
David Penson, M.D., the Paul V. Hamilton, M.D. and Virginia E. Howd Professor of Urologic Oncology, will become chair of Vanderbilt’s Department of Urologic Surgery, effective Jan. 1, 2015. -
April 2, 2014
VU study tracks urinary incontinence therapy
More than 15 million women in the United States are impacted by stress urinary incontinence (SUI) at a cost of nearly $20 billion a year to treat. -
March 27, 2014
Grant bolsters patient-centered outcomes research
Patient-centered outcomes research is the focus of a $3.3 million, five-year, institutional K12 training grant awarded to Vanderbilt University Medical Center by the Agency for Healthcare Research and Quality (AHRQ). -
January 24, 2014
Nine faculty honored with endowed chairs
Nine Vanderbilt University faculty members named to endowed chairs were honored for their academic achievements during a celebration Jan. 22 at the Student Life Center. -
May 23, 2013
VU to lead prostate cancer treatment research effort
David Penson, M.D., MPH, professor of Urologic Surgery, has received a $2 million research award from the Patient-Centered Outcomes Research Institute (PCORI) to study localized prostate cancer, the second leading cause of death among American men. -
February 28, 2013
New fluorescing agent shines light on bladder cancer cells
Two urologic surgeons at Vanderbilt-Ingram Cancer Center are among a leading group of cancer physicians using an innovative new imaging agent and blue light system to “light up” cancerous cells inside the bladder.